gabexate
Sign in to saveGabexate is a serine protease inhibitor which is used therapeutically (as gabexate mesilate) in the treatment of pancreatitis, disseminated intravascular coagulation, and as a regional anticoagulant for haemodialysis.
Research
928 papers- Efficacy of gabexate mesilate in preventing post endoscopic retrograde cholangiopancreatography pancreatitis: A meta-analysis of randomized clinical trials.Journal of the Formosan Medical Association = Taiwan yi zhi · 2021
- Gabexate in the prophylaxis of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials.BMC gastroenterology · 2007
- Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial.Gastrointestinal endoscopy · 2002
- Use of gabexate mesylate in Italian hospitals: a multicentre observational study.Journal of clinical pharmacy and therapeutics · 2003
- Somatostatin and gabexate for post-endoscopic retrograde cholangiopancreatography pancreatitis prevention: meta-analysis of randomized placebo-controlled trials.Journal of gastroenterology and hepatology · 2007
via PubMed
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 321.169
- Has use
- medication
Show 2 more facts
- chemical formula
- C₁₆H₂₃N₃O₄
- canonical SMILES
- CCOC(=O)C1=CC=C(C=C1)OC(=O)CCCCCN=C(N)N
Sources (2)
via Wikidata · CC0
~1 min read
Encyclopedic overview
1 sectionsContents
- References
Gabexate is a serine protease inhibitor which is used therapeutically (as gabexate mesilate) in the treatment of pancreatitis, disseminated intravascular coagulation, and as a regional anticoagulant for haemodialysis.
== References ==
Excerpted from Wikipedia’s “gabexate” article, available under the CC BY-SA 4.0 licence.